Skip to content

Evaluation of the effects of transperineal skeletal muscle electrical stimulation on pelvic floor muscle group strength.

Evaluation of the effects of transperineal skeletal muscle electrical stimulation on pelvic floor muscle group strength.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1032250610
Enrollment
10
Registered
2026-01-05
Start date
2026-01-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Urinary Incontinence Symptoms Stress urinary incontinence, Urinary incontinence, Pelvic floor muscle, Pelvic floor dysfunction, Female urinary incontinence

Interventions

Participants will perform training at home using a seated-type EMS device once daily for 15 minutes, as consistently as possible. The intervention period will be 12 weeks, and training may be perform
Electrical Muscle Stimulation device

Sponsors

Okayama Hisayo
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Women aged 30-59 years at the time of informed consent who have a history of childbirth. 2.Individuals who experience symptoms of stress urinary incontinence (urine leakage during sneezing, coughing, or physical activity) at least twice per week. 3.Individuals who are physically and mentally healthy. 4.Individuals who are able to use the EMS device on a daily basis in principle during the study period. 5.Individuals who are able to complete daily usage records throughout the study period.

Exclusion criteria

Exclusion criteria: 1.Individuals with a history of treatment for urinary incontinence or pelvic organ disorders, or a history of surgery involving the pelvic organs, urinary tract, or rectum. 2.Individuals who are currently performing pelvic floor muscle training. 3.Individuals who are pregnant or within one year postpartum. 4.Individuals with voiding dysfunction due to neurological disorders, or with a history of or current symptoms of cerebrovascular disease or neurological disorders (e.g., epilepsy). 5.Individuals with a history of heart disease, those with current or suspected cardiac symptoms, those receiving treatment for hypertension, individuals with venous thrombosis or suspected venous thrombosis, or those using a pacemaker. 6.Individuals with malignant tumors. 7.Individuals who have difficulty communicating in Japanese or completing questionnaires in Japanese. 8.Individuals who are deemed inappropriate for participation in the study by the investigator for any other reason. 9.Individuals who do not meet the safety criteria required for MRI examination.

Design outcomes

Primary

MeasureTime frame
Pelvic floor muscle contraction strength and pelvic floor muscle contraction duration (measured using a portable ultrasound imaging device).

Secondary

MeasureTime frame
1.Pelvic floor muscle position assessed by MRI 2.Records of EMS device usage 3.Interview-based subjective assessments

Contacts

Public ContactHisayo okayama

University of Tsukuba

okayama@md.tsukuba.ac.jp+81-29-853-8372

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026